Issued Patents All Time
Showing 1–25 of 42 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| RE50319 | Compounds and methods for treating cancer | Alan D'Andrea, Raphael Ceccaldi | 2025-03-04 |
| 12077540 | Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues | Pei-Yong Shi, Jimin Xu, Xuping Xie | 2024-09-03 |
| 12043602 | Fendiline derivatives | John F. Hancock, Dharini VAN DER HOEVEN, Jeffrey A. Frost, Na Ye, Pingyuan Wang | 2024-07-23 |
| 11773065 | Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists | John Arthur Allen, Pingyuan Wang, Daniel E. FELSING | 2023-10-03 |
| 11767303 | Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections | Hongmin Li, Zhong Li, Jimin Xu, Qing Zhang | 2023-09-26 |
| 11697813 | Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis | John J. Xu, Patrick Y. Lu, Qingfeng Li, Vera Simonenko | 2023-07-11 |
| 11618845 | Polymer dispersions for wax inhibition during stimulation treatment | Pierre-Emmanuel Dufils, David James Wilson, Zongming Xiu | 2023-04-04 |
| 11407752 | Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues | Pei-Yong Shi, Jimin Xu, Xuping Xie | 2022-08-09 |
| 11389433 | BRD4 inhibitor treatment of IgE-mediated diseases | Allan R. Brasier, Sanjiv Sur, Bing Tian | 2022-07-19 |
| 11224608 | Compounds and methods for treating cancer | Alan D'Andrea, Raphael Ceccaldi | 2022-01-18 |
| 11124489 | EPAC antagonists | Zhiqing Liu, Na Ye, Fang Mei, Xiaodong Cheng | 2021-09-21 |
| 11117865 | Inhibitors of bromodomain-containing protein 4 (BRD4) | Allan R. Brasier, Bing Tian, Zhiqing Liu, Haiying Chen, Erik Rytting | 2021-09-14 |
| 10975059 | Small molecule BRD4 modulators for HIV epigenetic regulation | Haitao Hu, Zhiqing Liu | 2021-04-13 |
| 10889543 | Fine-tune modulators of neuronal excitability for neuropsychiatric disorders | Fernanda Laezza, Zhiqing Liu, Syed Ali | 2021-01-12 |
| 10633363 | EPAC1 activators as HIV latency reversal agents (LRA) | Haitao Hu, Zhiqing Liu, Xiuzhen Fan | 2020-04-28 |
| 10570700 | Fracturing fluids and methods of treating hydrocarbon formations | Scott G. Nelson, Hong Sun, Leiming Li, Xiaolan Wang, Qi Qu | 2020-02-25 |
| 10457662 | Substituted amides for treating and preventing cancer | Nouri Neamati, Yuting Kuang, Na Ye | 2019-10-29 |
| 10335382 | Use of hydrogen sulfide synthesis inhibitors for cancer therapy | Mark HELLMICH, Csaba Szabo | 2019-07-02 |
| 10233385 | Well treatment methods and fluids with GLDA salt | Leiming Li, Magnus Legemah, Xiaolan Wang, Ahmed M. Gomaa, Hong Sun | 2019-03-19 |
| 10161223 | Use of superabsorbent polymers for pressure control and diversion applications | Harold Dean Brannon, Paul S. Carman, Leiming Li, Thomas Ray Starks, II, D. V. Satyanarayana Gupta +2 more | 2018-12-25 |
| 10138418 | Hydraulic fracturing composition, method for making and use of same | Hong Sun, Qi Qu, Michael Guerin | 2018-11-27 |
| 10113396 | Fracturing fluids and methods of treating hydrocarbon formations | Scott G. Nelson, Hong Sun, Leiming Li, Xiaolan Wang, Qi Qu | 2018-10-30 |
| 10072022 | Oridonin analogs, compositions, and methods related thereto | Chunyong Ding, Qiang Shen | 2018-09-11 |
| 9980936 | BH4 antagonists and methods related thereto | Xingming Deng, Chunyong Ding | 2018-05-29 |
| 9884863 | STAT3 inhibitor | Haijun Chen, Qiang Shen | 2018-02-06 |